Bio Works Technologies Ab Stock Last Dividend Paid
| BIOWKS Stock | SEK 0.91 0.07 8.33% |
Bio Works Technologies AB fundamentals help investors to digest information that contributes to Bio Works' financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Works' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Works stock.
Bio |
Bio Works Technologies AB Company Last Dividend Paid Analysis
Bio Works' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Bio Works Technologies AB has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all Sweden stocks average (which is currently at 0.0).
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Bio Fundamentals
| Return On Equity | -0.66 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (1.31) % | |||
| Operating Margin | (1.27) % | |||
| Current Valuation | 635.01 M | |||
| Shares Outstanding | 34.87 M | |||
| Shares Owned By Insiders | 54.85 % | |||
| Shares Owned By Institutions | 5.59 % | |||
| Price To Book | 8.03 X | |||
| Price To Sales | 19.71 X | |||
| Revenue | 21.91 M | |||
| Gross Profit | 53.01 M | |||
| EBITDA | (8.6 M) | |||
| Net Income | (12.94 M) | |||
| Cash And Equivalents | 46.35 M | |||
| Cash Per Share | 2.40 X | |||
| Current Ratio | 9.14 X | |||
| Book Value Per Share | 2.55 X | |||
| Cash Flow From Operations | (13.37 M) | |||
| Earnings Per Share | (0.41) X | |||
| Target Price | 27.0 | |||
| Number Of Employees | 36 | |||
| Beta | 0.99 | |||
| Market Capitalization | 718.4 M | |||
| Total Asset | 120.86 M | |||
| Net Asset | 120.86 M |
About Bio Works Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Works Technologies AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Works using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Works Technologies AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Bio Stock
Bio Works financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Works security.